NYSE · Specialty Chemicals · USD
Cabot Corporation (CBT) Stock Analysis
Cabot Corporation (CBT) is a Specialty Chemicals stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
CBT Key Statistics
As of Oct 21, 2026Trading
- Open
- $73.78
- Previous Close
- $73.62
- Day's Range
- 72.62–73.86
- 52-Week Range
- 58.33–94.53
- Volume
- 411.04K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.82
Valuation
- Market Cap
- $3.88B
- P/E Ratio
- 21.05
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 10.76
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 1.00
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 1.07
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 3.57
Financials (FY)
- Revenue (FY)
- $3.71B−7.04%
- Net Income (FY)
- $331.00M−12.89%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 5.23%
- Shares Outstanding
- 51.63M
- 1-Year Return
- +5.77%
Dividend and dates
- Dividend
- 2.44%
- Ex-Dividend Date
- August 28, 2026
- Earnings Date
- November 2, 2026
- Avg Volume
- 411.36K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, CBT closed at $73.78, +5.77% over 1 year.
Cabot Corporation (CBT) has a market capitalization of $3.88B.
In fiscal 2025, CBT reported revenue of $3.71B.
CBT Stock Return by Calendar Year
Cabot Corporation (CBT) 10-year return: what $10,000 became
- 1 year
- $10,000 $10,577
- +5.77%
- 5 years
- $10,000 $15,163
- +51.63%
- 10 years
- $10,000 $18,065
- +80.65%
If you had invested $10,000 in Cabot Corporation (CBT) 10 years ago, at the close on October 21, 2016, it would have been worth $18,065 at the close on October 21, 2026: +80.65% in total, +6.09% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +12.59% |
| 2025 | −25.67% |
| 2024 | +11.25% |
| 2023 | +27.63% |
| 2022 | +21.38% |
| 2021 | +28.40% |
| 2020 | −2.16% |
| 2019 | +14.25% |
| 2018 | −28.70% |
| 2017 | +24.65% |
| 2016 (partial year) | +4.39% |
As of October 21, 2026.
CBT Revenue and Earnings by Fiscal Year
FY ends September| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $3.71B | $331.00M | 8.9% |
| 2024 | $3.99B | $380.00M | 9.5% |
| 2023 | $3.93B | $445.00M | 11.3% |
| 2022 | $4.32B | $209.00M | 4.8% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $3.71B | $940.00M | $621.00M | $331.00M | 8.9% |
| 2024 | $3.99B | $960.00M | $614.00M | $380.00M | 9.5% |
| 2023 | $3.93B | $839.00M | $529.00M | $445.00M | 11.3% |
| 2022 | $4.32B | $885.00M | $572.00M | $209.00M | 4.8% |
Annual figures as reported, in the company's reporting currency. As of September 30, 2025.
CBT Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $0.92 | 2 | — |
| 2025 | $1.78 | 4 | +5.3% |
| 2024 | $1.69 | 4 | +7.6% |
| 2023 | $1.57 | 4 | +6.1% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $0.92 | 2 | — |
| 2025 | $1.78 | 4 | +5.3% |
| 2024 | $1.69 | 4 | +7.6% |
| 2023 | $1.57 | 4 | +6.1% |
| 2022 | $1.48 | 4 | +4.2% |
| 2021 | $1.42 | 4 | +1.4% |
| 2020 | $1.40 | 4 | +1.4% |
| 2019 | $1.38 | 4 | +5.7% |
| 2018 | $1.31 | 4 | +4.8% |
| 2017 | $1.25 | 4 | +315.0% |
| 2016 | $0.30 | 1 | — |
Most recent payment: $0.46 per share, ex-dividend May 29, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
CBT Valuation vs Specialty Chemicals Median
Median of 70 stocks| Metric | CBT | Specialty Chemicals median | vs median |
|---|---|---|---|
| P/E | 21.05 | 28.29 | 26% below |
| P/S ratio | 1.07 | 1.59 | 33% below |
| Profit margin | 5.23% | 2.70% | 2.5 pts above |
Medians across 70 Specialty Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Cabot Corporation to Announce Fourth Quarter Fiscal 2026 Operating Results
YahooHere's Why You Should Add Cabot Stock to Your Portfolio Now
YahooAre Investors Undervaluing Cabot (CBT) Right Now?
YahooUBS Maintains Neutral on Cabot, Lowers Price Target to $86
BenzingaIs Cabot (CBT) Outperforming Other Basic Materials Stocks This Year?
YahooMesoporous Carbons Market - Global Strategic Business Report: Capitalize on the $1.4 Billion Revenue Shift to $5.3 Billion by 2030 as Tariffs Rewire Supply Chains and BASF, Cabot, Calgon Carbon, Kuraray and Haycarb Battle for Energy Storage Leadership
Yahoo
All 20 articles ↓Show fewer ↑
Cabot Reports Q3 2026 Results: Full Earnings Call Transcript
BenzingaActivated Carbon Market Forecasts Growth from $7.79B (2026) to $14.01B by 2032, Profiling Cabot Corporation, Kuraray, Calgon Carbon & Jacobi Carbons
YahooCabot Properties to Acquire Modern Logistics Development in the Hanover Region of Germany
YahooCabot Expands Battery Materials Platform With $50M DOE Grant
YahooWhat Is Cabot (CBT) Planning After Its $50 Million DOE Battery Materials Grant?
YahooCabot Corporation to Expand North American Battery Materials Platform Through Modified $50 Million DOE Grant
YahooWill Cabot’s (CBT) CFO-to-CEO Shift and Interim Finance Leader Reframe Its Strategic Narrative?
YahooCabot Corporation Appoints Steve Delahunt as Interim Chief Financial Officer
YahooCabot Appoints Steve Delahunt As Interim CFO, Effective October 1
BenzingaCabot Stock Rallies 17% in 6 Months: Here's What's Driving the Upside
YahooWhy Is Cabot (CBT) Down 1.6% Since Last Earnings Report?
YahooReasons Why You Should Retain Cabot Stock in Your Portfolio Now
YahooCabot Wealth Management Becomes First Customer to Leverage Ridgeline Intelligent Outcomes
YahooMajor Exercise Alert: Sean D Keohane Exercises Options Worth $4.41M At Cabot
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Specialty Chemicals Stocks
Linde plc
$230.75B
SHWThe Sherwin-Williams Company
$81.88B
ECLEcolab Inc.
$80.76B
APDAir Products and Chemicals, Inc.
$67.40B
PPGPPG Industries, Inc.
$24.49B
IFFInternational Flavors & Fragrances Inc.
$23.23B
Popular Basic Materials Stocks
BHP Group Limited
$211.50B
SCCOSouthern Copper Corporation
$167.24B
RIORio Tinto Group
$141.37B
NEMNewmont Corporation
$123.47B
FCXFreeport-McMoRan Inc.
$98.94B












